NASDAQ:CVRX CVRx (CVRX) Stock Price, News & Analysis → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free cvrx Stock Alerts $8.29 +0.21 (+2.60%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$7.89▼$8.3550-Day Range$7.27▼$21.8752-Week Range$7.06▼$33.13Volume197,961 shsAverage Volume358,100 shsMarket Capitalization$179.06 millionP/E RatioN/ADividend YieldN/APrice Target$16.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get CVRx alerts: Email Address CVRx MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside100.2% Upside$16.60 Price TargetShort InterestBearish9.06% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 2 Articles This WeekInsider TradingSelling Shares$55,761 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.39) to ($1.85) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.05 out of 5 starsMedical Sector358th out of 919 stocksSurgical & Medical Instruments Industry53rd out of 99 stocks 4.3 Analyst's Opinion Consensus RatingCVRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCVRx has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CVRx's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.06% of the float of CVRx has been sold short.Short Interest Ratio / Days to CoverCVRx has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in CVRx has recently increased by 10.64%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCVRx does not currently pay a dividend.Dividend GrowthCVRx does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CVRX. Previous Next 2.3 News and Social Media Coverage News SentimentCVRx has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for CVRx this week, compared to 2 articles on an average week.Search Interest8 people have searched for CVRX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows4 people have added CVRx to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CVRx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,761.00 in company stock.Percentage Held by Insiders18.90% of the stock of CVRx is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.27% of the stock of CVRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVRx's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for CVRx are expected to grow in the coming year, from ($2.39) to ($1.85) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CVRx is -3.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CVRx is -3.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCVRx has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about CVRx's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceMillionaire Investor makes surprising election predictionMillionaire Investor Makes Surprising Election Prediction Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day.Click here for the full story… About CVRx Stock (NASDAQ:CVRX)CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Read More CVRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CVRX Stock News HeadlinesMay 16 at 7:00 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRXMay 16 at 7:30 AM | globenewswire.comCVRx Announces Key Senior Leadership Team HiresMay 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRXMay 3, 2024 | finance.yahoo.comCVRx, Inc. (NASDAQ:CVRX) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMay 2, 2024 | msn.comCVRx stock plunges 42% in wake of Q1 report, updated forecastMay 2, 2024 | msn.comWilliam Blair Downgrades CVRx (CVRX)May 2, 2024 | finance.yahoo.comCVRx First Quarter 2024 Earnings: Misses ExpectationsMay 1, 2024 | finance.yahoo.comCVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call TranscriptMay 1, 2024 | markets.businessinsider.comCVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024May 1, 2024 | benzinga.comUS Stocks Mixed; Amazon Posts Upbeat EarningsMay 1, 2024 | finance.yahoo.comCVRx Inc (CVRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Setting ...May 1, 2024 | finance.yahoo.comQ1 2024 CVRx Inc Earnings CallMay 1, 2024 | investorplace.comWhy Is CVRx (CVRX) Stock Down 32% Today?April 30, 2024 | marketwatch.comStocks to Watch: Pinterest, Root, Clorox, Denny's, CVRxApril 30, 2024 | marketwatch.comCVRx Shares Tumble 26% After Execution Issues Dent RevenueApril 30, 2024 | finance.yahoo.comCVRx Reports First Quarter 2024 Financial and Operating ResultsApril 30, 2024 | finance.yahoo.comCVRx Inc (CVRX) Reports Q1 2024 Results: Revenue Growth Amid ChallengesApril 24, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and CVRx (CVRX)April 16, 2024 | finance.yahoo.comCVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024April 15, 2024 | globenewswire.comCVRx announces availability of additional data supporting long-term benefits of BarostimApril 15, 2024 | globenewswire.comCVRx announces availability of additional data supporting long-term benefits of BarostimMarch 28, 2024 | fool.comWhat Companies Does Johnson & Johnson Own?March 21, 2024 | bizjournals.comTarget to double bonuses for salaried employees in signal of profit growthMarch 18, 2024 | markets.businessinsider.comCraig-Hallum Reaffirms Their Hold Rating on ProSomnus (OSA)February 25, 2024 | msn.comCVRx (CVRX) Price Target Increased by 10.54% to 33.15See More Headlines Receive CVRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVRx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today5/18/2024Next Earnings (Estimated)7/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:CVRX CUSIPN/A CIK1235912 Webwww.cvrx.com Phone763-416-2840Fax763-416-2841Employees200Year FoundedN/APrice Target and Rating Average Stock Price Target$16.60 High Stock Price Target$23.00 Low Stock Price Target$13.00 Potential Upside/Downside+100.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($2.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,200,000.00 Net Margins-123.58% Pretax Margin-123.22% Return on Equity-66.05% Return on Assets-46.99% Debt Debt-to-Equity Ratio0.44 Current Ratio12.18 Quick Ratio12.86 Sales & Book Value Annual Sales$39.29 million Price / Sales4.56 Cash FlowN/A Price / Cash FlowN/A Book Value$3.07 per share Price / Book2.70Miscellaneous Outstanding Shares21,600,000Free Float17,514,000Market Cap$179.06 million OptionableOptionable Beta1.35 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Kevin Hykes (Age 58)President, CEO & Director Mr. Jared Oasheim (Age 40)Chief Financial Officer Comp: $446.1kMr. Paul Verrastro (Age 61)Chief Marketing & Strategy Officer Comp: $529.84kMr. Paul PignatoVice President of OperationsMs. Jonelle R. Burnham (Age 53)Vice President & General Counsel Mr. Craig Palmer (Age 47)Senior Vice President of US Sales More ExecutivesKey CompetitorsClearPoint NeuroNASDAQ:CLPTQuipt Home MedicalNASDAQ:QIPTAccurayNASDAQ:ARAYAlpha Tau MedicalNASDAQ:DRTSOrchestra BioMedNASDAQ:OBIOView All CompetitorsInsiders & InstitutionsSilvercrest Asset Management Group LLCBought 105,198 shares on 5/16/2024Ownership: 1.176%FourWorld Capital Management LLCBought 20,550 shares on 5/16/2024Ownership: 0.095%Johnson & JohnsonBought 607,855 shares on 5/10/2024Ownership: 19.006%Vanguard Group Inc.Bought 31,720 shares on 5/10/2024Ownership: 2.753%Lord Abbett & CO. LLCSold 185,869 shares on 5/9/2024Ownership: 2.727%View All Insider TransactionsView All Institutional Transactions CVRX Stock Analysis - Frequently Asked Questions Should I buy or sell CVRx stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CVRx in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CVRX shares. View CVRX analyst ratings or view top-rated stocks. What is CVRx's stock price target for 2024? 6 analysts have issued 12 month price objectives for CVRx's shares. Their CVRX share price targets range from $13.00 to $23.00. On average, they expect the company's share price to reach $16.60 in the next year. This suggests a possible upside of 100.2% from the stock's current price. View analysts price targets for CVRX or view top-rated stocks among Wall Street analysts. How have CVRX shares performed in 2024? CVRx's stock was trading at $31.44 at the beginning of 2024. Since then, CVRX stock has decreased by 73.6% and is now trading at $8.29. View the best growth stocks for 2024 here. When is CVRx's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024. View our CVRX earnings forecast. How were CVRx's earnings last quarter? CVRx, Inc. (NASDAQ:CVRX) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.08. The company earned $3.40 million during the quarter, compared to analyst estimates of $3.42 million. CVRx had a negative net margin of 123.58% and a negative trailing twelve-month return on equity of 66.05%. What guidance has CVRx issued on next quarter's earnings? CVRx issued an update on its second quarter 2024 earnings guidance on Tuesday, April, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $11.3 million-$12.3 million, compared to the consensus revenue estimate of $13.1 million. When did CVRx IPO? CVRx (CVRX) raised $100 million in an initial public offering on Wednesday, June 30th 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share. Who are CVRx's major shareholders? CVRx's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Johnson & Johnson (19.01%), Vanguard Group Inc. (2.75%), Lord Abbett & CO. LLC (2.73%), Silvercrest Asset Management Group LLC (1.18%), GSG Advisors LLC (0.17%) and FourWorld Capital Management LLC (0.10%). Insiders that own company stock include & Johnson Johnson, Kirk G Nielsen, Mudit K Jain, Nea Partners 10 L P and Paul Verrastro. View institutional ownership trends. How do I buy shares of CVRx? Shares of CVRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CVRX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
